Literature DB >> 15172237

Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection.

Morihito Okada1, Wataru Nishio, Toshihiko Sakamoto, Kazuya Uchino, Tsuyoshi Yuki, Akio Nakagawa, Noriaki Tsubota.   

Abstract

BACKGROUND: Lung cancer is still the most common cause of death due to cancer. Although the 5-year survival rate of patients with lung cancer is reported to be increasing, whether the surgical results have actually been improving or not is controversial. We reviewed our experience to evaluate time trends of surgical outcomes in patients with nonsmall cell lung cancer.
METHODS: We reviewed the clinical records of 1465 consecutive patients with proven primary nonsmall cell carcinoma who underwent complete removal of the primary tumor together with hilar and mediastinal lymph nodes from 1985 to 1995 (early era) and from 1996 to 2002 (late era). The clinical characteristics, surgical outcome, and overall survival of the patients were analyzed, and data from the two eras were compared.
RESULTS: There were 694 patients in the early era and 771 in the late era. As for their characteristics, elder age, female sex, adenocarcinoma, earlier stage of disease and smaller size of tumor were more frequently encountered in the late era. Lobectomy was the most common procedure performed during both periods, and in the late era, the rate of segmentectomy was doubled (11% to 25%) whereas that of pneumonectomy was much less (6% to 1%). Although the frequency of operative deaths in the two eras did not differ (0.3%), that of in-hospital deaths and of postoperative complications decreased significantly in the late era (2% to 0.5% and 28% to 12%, respectively). A significant improvement in survival probability was observed in patients with pathologic stage IA (p < 0.0001), IB (p = 0.0477), and III disease (p = 0.00120) but not in those with pathologic stage II disease (p = 0.5353). Also, the multivariate analysis of patients with pathologic stage I or III demonstrated that age, sex, and size of the tumor were significant prognostic determinants, and confirmed that the recent prolonged survivals remained significant even after simultaneous adjustment for other factors.
CONCLUSIONS: These data indicate a significant recent improvement in surgical outcomes after stratification of various prognostic variables although careful consideration should be given to the retrospective nature of this study.

Entities:  

Mesh:

Year:  2004        PMID: 15172237     DOI: 10.1016/j.athoracsur.2004.01.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.

Authors:  Katsuhiro Okuda; Risa Oda; Ayumi Suzuki; Tadashi Sakane; Osamu Kawano; Hiroshi Haneda; Satoru Moriyama; Ryoichi Nakanishi
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 2.  Decision making in patients with pulmonary nodules.

Authors:  David E Ost; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2011-10-06       Impact factor: 21.405

3.  Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis.

Authors:  Kei Miyoshi; Takeshi Mimura; Koichiro Iwanaga; Shuji Adachi; Noriaki Tsubota; Morihito Okada
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

4.  Clinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours.

Authors:  Y Hatayama; M Aoki; H Kawaguchi; K Hirose; M Sato; H Akimoto; M Tanaka; I Fujioka; K Ichise; S Ono; Y Takai
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

5.  Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.

Authors:  Sarah E Billmeier; John Z Ayanian; Alan M Zaslavsky; David R Nerenz; Michael T Jaklitsch; Selwyn O Rogers
Journal:  J Natl Cancer Inst       Date:  2011-09-29       Impact factor: 13.506

6.  Survival after resection for primary lung cancer: a population based study of 3211 resected patients.

Authors:  T-E Strand; H Rostad; B Møller; J Norstein
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

7.  Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis.

Authors:  Maristela L Onozato; Alexandra E Kovach; Beow Y Yeap; Vicente Morales-Oyarvide; Veronica E Klepeis; Swathi Tammireddy; Rebecca S Heist; Eugene J Mark; Dora Dias-Santagata; A John Iafrate; Yukako Yagi; Mari Mino-Kenudson
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

8.  The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.

Authors:  Jung Yong Hong; Moon Ki Choi; Ji Eun Uhm; Min Jae Park; Jeeyun Lee; Yeon Hee Park; Jin Seok Ahn; Keunchil Park; Joung Ho Han; Myung Ju Ahn
Journal:  Med Oncol       Date:  2008-11-07       Impact factor: 3.064

9.  Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China.

Authors:  Wen-Li Wang; Yang Shen-Tu; Zhi-Qiang Wang
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

10.  Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.

Authors:  Melanie Subramanian; Timothy McMurry; Bryan F Meyers; Varun Puri; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2018-03-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.